Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.45 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.45 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.45 |
| ▸ | AR | P10275 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7665374 | 0.90 | SMN1; SMN2 (0.61) | SMN1; SMN2ALDH1A1KMT2AMAPTTDP1 | |
| SCHEMBL550921 | 0.86 | SMN1; SMN2 (0.57) | SMN1; SMN2ALDH1A1KMT2AMAPTNPC1 | |
| SCHEMBL13280233 | 0.86 | ALDH1A1 (0.52) | SMN1; SMN2ALDH1A1KMT2AMAPTTDP1 | |
| SCHEMBL10514258 | 0.85 | SMN1; SMN2 (0.56) | SMN1; SMN2ALDH1A1KMT2AMAPTTDP1 | |
| SCHEMBL20968303 | 0.85 | SMN1; SMN2 (0.56) | SMN1; SMN2ALDH1A1KMT2AMAPTTDP1 | |
| SCHEMBL7723906 | 0.84 | SMN1; SMN2 (0.68) | SMN1; SMN2ALDH1A1KMT2AMAPTTDP1 | |
| SCHEMBL4420346 | 0.83 | SMN1; SMN2 (0.64) | SMN1; SMN2ALDH1A1KMT2AMAPTTDP1 | |
| SCHEMBL550516 | 0.82 | SMN1; SMN2 (0.63) | SMN1; SMN2ALDH1A1KMT2AMAPTTDP1 | |
| SCHEMBL17737227 | 0.82 | SMN1; SMN2 (0.53) | SMN1; SMN2KMT2AMAPTARMEN1 | |
| SCHEMBL14114749 | 0.81 | SMN1; SMN2 (0.61) | SMN1; SMN2ALDH1A1KMT2AMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10968392-B2 | Liquid crystal aligning agent for photoalignment, liquid crystal alignment film and liquid crystal display device using it, and diamine and polymer | JNC CORPORATION (JP) | 2021-04-06 | — | — | US | disclosed |
| US-20190127643-A1 | LIQUID CRYSTAL ALIGNING AGENT FOR PHOTOALIGNMENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE USING IT, AND DIAMINE AND POLYMER | JNC CORPORATION (JP) | 2019-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10968392-B2 | Liquid crystal aligning agent for photoalignment, liquid crystal alignment film and liquid crystal display device using it, and diamine and polymer | DDT, DCLRE1A, DVL1 | SMN1; SMN2 3082/4885ALDH1A1 2734/4885KMT2A 523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.